Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
At the agent level, in the established cardiovascular disease subgroup analysis, tirzepatide was associated with a larger relative point-estimate reduction in MACE versus placebo (HR 0.73 [0.590.90]) (Supplementary Figure S2) compared with the broader network (HR 0.81 [0.700.94]) (Fig
Furthermore, this phenomenon is exclusive for VPA as treatment with other anticonvulsants, such as carbamazepine or lamotrigine did not trigger alteration in the expression of SCN3A
The primary endpoint was all-cause mortality, and secondary endpoints were AMI, ischemic stroke, hemorrhagic stroke, atrial fibrillation (A-Fib)/flutter, cardiac arrest, readmission rate, and achievement of HbA1c (blood sugar) levels below 7%
Photographed by KIM ANGELA SANTOS of KLIQ INC.
Alternatives to hysterectomy: the burden of fibroids and the quality of life
Hepatology 36 , 781791 (2002)
